4
t h
E u r o S c i C o n C o n f e r e n c e o n
Neurology & Neurological
Disorders
Neurology 2018
J u l y 1 2 - 1 3 , 2 0 1 8
P a r i s , F r a n c e
Page 107
Journal of Neurology and Neuroscience
ISSN: 2171-6625
G
lioblastoma is a lethal cancer with a median survival of about 15 months. It is a well-known fact that most Glioblastoma’s
are rich in collagens. Specifically, the mesenchymal subtype of Glioblastoma, which has the worst prognosis, is enriched
with numerous extracellular matrix proteins such as collagens. While collagen accumulation can be viewed as a downstream
effect of mesenchymal differentiation, it was found that the feed forward increases in collagen, extracellular matrix stiffness
and biomechanical influences cause enhanced selfrenewal and mesenchymal transition in glioma stem cells with a consequent
increase in treatment resistance of these cells. Further, recent studies have also shown that mechanical stress plays an
overarching role in the regulation of TAZ signaling. TAZ is a mediator of mesenchymal differentiation in glioma, which relates
with collagen stiffness, promotes mesenchymal transition and gliomagenesis via TAZ signaling. D-penicillamine is a known
inhibitor of collagen maturation, which acts by increasing the conversion of insoluble to soluble collagen and disrupting the
formation of intermolecular bonds. The therapeutic benefit of D-penicillamine has not been extensively evaluated in Glioblastoma
especially in the context of glioma stem cells, which represent faithful models of this disease. Directing therapeutic agents such
as D-penicillamine towards deeply embedded brain tumours with biophysical barriers such as blood brain barrier and collagen
remains a challenge. Hence, in the present study it is proposed to load D-penicillamine into Nano lipid carriers, which can
accumulate passively in tumours via leaky tumour vasculature, caused by focused ultrasound. These triggered release strategies
disrupt the blood brain barrier, confirming deep penetration in tumours, and overcome the biophysical constraints, which tackle
both the challenges (drug delivery and collagen disruption) simultaneously.
naren.mahe@gmail.comD-PENICILLAMINE LOADED NANO LIPID CARRIERS FOR
TARGETING GLIOBLASTOMA
B. Mahendran
1
, DV Gowda
2
, VVS Narayana Reddy
3
1
Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Mysuru, India
2
Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Mysuru, India
3
Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, India
J Neurol Neurosci 2018, Volume: 9
DOI: 10.21767/2171-6625-C1-009